172 related articles for article (PubMed ID: 33958660)
1. Nanoparticle-mediated tumor cell expression of mIL-12 via systemic gene delivery treats syngeneic models of murine lung cancers.
Ahn HH; Carrington C; Hu Y; Liu HW; Ng C; Nam H; Park A; Stace C; West W; Mao HQ; Pomper MG; Ullman CG; Minn I
Sci Rep; 2021 May; 11(1):9733. PubMed ID: 33958660
[TBL] [Abstract][Full Text] [Related]
2. Antitumoral efficacy of DNA nanoparticles in murine models of lung cancer and pulmonary metastasis.
Rodrigo-Garzón M; Berraondo P; Ochoa L; Zulueta JJ; González-Aseguinolaza G
Cancer Gene Ther; 2010 Jan; 17(1):20-7. PubMed ID: 19575045
[TBL] [Abstract][Full Text] [Related]
3. Combined Local Pulmonary and Systemic Delivery of AT2R Gene by Modified TAT Peptide Nanoparticles Attenuates Both Murine and Human Lung Carcinoma Xenografts in Mice.
Ishiguro S; Alhakamy NA; Uppalapati D; Delzeit J; Berkland CJ; Tamura M
J Pharm Sci; 2017 Jan; 106(1):385-394. PubMed ID: 27769520
[TBL] [Abstract][Full Text] [Related]
4. Polyethyleneimine and DNA nanoparticles-based gene therapy for acute lung injury.
Lin EH; Chang HY; Yeh SD; Yang KY; Hu HS; Wu CW
Nanomedicine; 2013 Nov; 9(8):1293-303. PubMed ID: 23727098
[TBL] [Abstract][Full Text] [Related]
5. Tumor-specific gene delivery mediated by a novel peptide-polyethylenimine-DNA polyplex targeting aminopeptidase N/CD13.
Moffatt S; Wiehle S; Cristiano RJ
Hum Gene Ther; 2005 Jan; 16(1):57-67. PubMed ID: 15703489
[TBL] [Abstract][Full Text] [Related]
6. Integrating disulfides into a polyethylenimine gene carrier selectively boosts significant transfection activity in lung tissue enabling robust IL-12 gene therapy against metastatic lung cancers.
Liu J; Yu Y; Zhao J; Zhao P; Wen X; Zhuang Z; Lin C
Mater Sci Eng C Mater Biol Appl; 2021 Sep; 128():112358. PubMed ID: 34474905
[TBL] [Abstract][Full Text] [Related]
7. A nanoparticle formulation that selectively transfects metastatic tumors in mice.
Yang J; Hendricks W; Liu G; McCaffery JM; Kinzler KW; Huso DL; Vogelstein B; Zhou S
Proc Natl Acad Sci U S A; 2013 Sep; 110(36):14717-22. PubMed ID: 23959886
[TBL] [Abstract][Full Text] [Related]
8. Cationic liposome mediated delivery of FUS1 and hIL-12 coexpression plasmid demonstrates enhanced activity against human lung cancer.
Ren J; Yu C; Wu S; Peng F; Jiang Q; Zhang X; Zhong G; Shi H; Chen X; Su X; Luo X; Zhu W; Wei Y
Curr Cancer Drug Targets; 2014; 14(2):167-80. PubMed ID: 24410728
[TBL] [Abstract][Full Text] [Related]
9. Lung gene therapy with highly compacted DNA nanoparticles that overcome the mucus barrier.
Suk JS; Kim AJ; Trehan K; Schneider CS; Cebotaru L; Woodward OM; Boylan NJ; Boyle MP; Lai SK; Guggino WB; Hanes J
J Control Release; 2014 Mar; 178():8-17. PubMed ID: 24440664
[TBL] [Abstract][Full Text] [Related]
10. Antitumoral efficacy by systemic delivery of heparin conjugated polyethylenimine-plasmid interleukin-15 complexes in murine models of lung metastasis.
Zhou X; Li X; Gou M; Qiu J; Li J; Yu C; Zhang Y; Zhang N; Teng X; Chen Z; Luo C; Wang Z; Liu X; Shen G; Yang L; Qian Z; Wei Y; Li J
Cancer Sci; 2011 Jul; 102(7):1403-9. PubMed ID: 21564417
[TBL] [Abstract][Full Text] [Related]
11. Systemic administration of naked DNA encoding interleukin 12 for the treatment of human papillomavirus DNA-positive tumor.
Lui VW; He Y; Falo L; Huang L
Hum Gene Ther; 2002 Jan; 13(2):177-85. PubMed ID: 11812275
[TBL] [Abstract][Full Text] [Related]
12. Self-assembling micelle-like nanoparticles based on phospholipid-polyethyleneimine conjugates for systemic gene delivery.
Ko YT; Kale A; Hartner WC; Papahadjopoulos-Sternberg B; Torchilin VP
J Control Release; 2009 Jan; 133(2):132-8. PubMed ID: 18929605
[TBL] [Abstract][Full Text] [Related]
13. Polyethylenimine-DNA solid particles for gene delivery.
Chen T; Wang Z; Wang R; Lu T; Wang W
J Drug Target; 2007 Dec; 15(10):714-20. PubMed ID: 18041639
[TBL] [Abstract][Full Text] [Related]
14. Intratumoral injection of interleukin-12 plasmid DNA, either naked or in complex with cationic lipid, results in similar tumor regression in a murine model.
Shi F; Rakhmilevich AL; Heise CP; Oshikawa K; Sondel PM; Yang NS; Mahvi DM
Mol Cancer Ther; 2002 Sep; 1(11):949-57. PubMed ID: 12481417
[TBL] [Abstract][Full Text] [Related]
15. Eradication of osteosarcoma lung metastases following intranasal interleukin-12 gene therapy using a nonviral polyethylenimine vector.
Jia SF; Worth LL; Densmore CL; Xu B; Zhou Z; Kleinerman ES
Cancer Gene Ther; 2002 Mar; 9(3):260-6. PubMed ID: 11896442
[TBL] [Abstract][Full Text] [Related]
16. Tumor efficacy and biodistribution of linear polyethylenimine-cholesterol/DNA complexes.
Furgeson DY; Yockman JW; Janat MM; Kim SW
Mol Ther; 2004 Jun; 9(6):837-45. PubMed ID: 15194050
[TBL] [Abstract][Full Text] [Related]
17. Formulating the magic bullet: barriers to clinical translation of nanoparticle cancer gene therapy.
Hendricks WP; Yang J; Sur S; Zhou S
Nanomedicine (Lond); 2014; 9(8):1121-4. PubMed ID: 25118704
[No Abstract] [Full Text] [Related]
18. Nanoparticle-mediated interleukin-12 cancer gene therapy.
Hallaj-Nezhadi S; Lotfipour F; Dass C
J Pharm Pharm Sci; 2010; 13(3):472-85. PubMed ID: 21092717
[TBL] [Abstract][Full Text] [Related]
19. Nanoparticle based systemic gene therapy for lung cancer: molecular mechanisms and strategies to suppress nanoparticle-mediated inflammatory response.
Gopalan B; Ito I; Branch CD; Stephens C; Roth JA; Ramesh R
Technol Cancer Res Treat; 2004 Dec; 3(6):647-57. PubMed ID: 15560723
[TBL] [Abstract][Full Text] [Related]
20. Systemic delivery of siRNA via LCP nanoparticle efficiently inhibits lung metastasis.
Yang Y; Li J; Liu F; Huang L
Mol Ther; 2012 Mar; 20(3):609-15. PubMed ID: 22186791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
